• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.

作者信息

Reolid Alejandra, Armesto Susana, Sahuquillo-Torralba Antonio, Torres Tiago, Feltes Rosa, Vilarrasa Eva, Belinchón Isabel, Cueva Pablo de la, Rodríguez Lourdes, Romero-Maté Alberto, Vidal David, Coto-Segura Pablo, Herrera-Acosta Enrique, Riera-Monroig Josep, Salgado Laura, Llamas-Velasco Mar, Daudén Esteban

机构信息

Hospital Universitario de la Princesa, Madrid, Spain.

Hospital Universitario Marqués de Valdecilla, Santander, Spain.

出版信息

J Am Acad Dermatol. 2022 Sep;87(3):705-709. doi: 10.1016/j.jaad.2022.05.047. Epub 2022 May 28.

DOI:10.1016/j.jaad.2022.05.047
PMID:35640798
Abstract
摘要

相似文献

1
Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.在日常临床实践中，司库奇尤单抗对治疗顽固性掌跖银屑病和掌跖脓疱型银屑病有效。
J Am Acad Dermatol. 2022 Sep;87(3):705-709. doi: 10.1016/j.jaad.2022.05.047. Epub 2022 May 28.
2
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study.司库奇尤单抗治疗掌跖银屑病：一项为期2年的多中心真实世界观察性研究。
Expert Opin Biol Ther. 2022 Apr;22(4):547-554. doi: 10.1080/14712598.2022.2029841. Epub 2022 Jan 20.
3
Successful treatment with secukinumab in a patient with generalized pustular psoriasis preceded by palmoplantar lesions.一名掌跖部病变先于泛发性脓疱型银屑病患者使用司库奇尤单抗治疗成功。
J Dermatol. 2023 Dec;50(12):e413-e414. doi: 10.1111/1346-8138.16919. Epub 2023 Aug 14.
4
Palmoplantar pustulosis emerged on a case of generalized pustular psoriasis successfully treated by secukinumab.掌跖脓疱病出现在一例用司库奇尤单抗成功治疗的泛发性脓疱型银屑病患者身上。
J Dermatol. 2019 Dec;46(12):e468-e469. doi: 10.1111/1346-8138.15082. Epub 2019 Sep 9.
5
Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis.司库奇尤单抗成功治疗顽固性青少年泛发性脓疱型银屑病。
J Dermatol. 2020 Mar;47(3):e77-e78. doi: 10.1111/1346-8138.15228. Epub 2020 Jan 6.
6
Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis.优特克单抗治疗掌跖脓疱病和掌跖脓疱型银屑病的疗效。
Int J Dermatol. 2014 Oct;53(10):e464-6. doi: 10.1111/ijd.12511. Epub 2014 Jun 25.
7
Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial.司库奇尤单抗治疗中重度掌跖银屑病患者的持续疗效：来自随机、双盲、安慰剂对照试验GESTURE的2.5年结果
Br J Dermatol. 2020 Apr;182(4):889-899. doi: 10.1111/bjd.18331. Epub 2019 Dec 15.
8
Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study.司库奇尤单抗治疗中重度掌跖脓疱型银屑病：2PRECISE 研究结果。
J Am Acad Dermatol. 2019 May;80(5):1344-1352. doi: 10.1016/j.jaad.2019.01.066. Epub 2019 Feb 1.
9
Real world data from the use of secukinumab in the treatment of moderate-to-severe psoriasis, including scalp and palmoplantar psoriasis: A 104-week clinical study.使用司库奇尤单抗治疗中重度银屑病（包括头皮和掌跖部银屑病）的真实世界数据：一项 104 周的临床研究。
Dermatol Ther. 2019 Sep;32(5):e13006. doi: 10.1111/dth.13006. Epub 2019 Jul 15.
10
Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3).依奇珠单抗对比依那西普和安慰剂治疗中重度斑块状银屑病和非脓疱性掌跖银屑病患者的疗效：三项 3 期临床试验（UNCOVER-1、UNCOVER-2 和 UNCOVER-3）结果。
J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1686-1692. doi: 10.1111/jdv.14237. Epub 2017 Apr 26.

引用本文的文献

1
Short-Term Relief with Upadacitinib: A Case Report of Palmoplantar Pustulosis in a Pediatric Patient.乌帕替尼带来的短期缓解：一名儿科掌跖脓疱病患者的病例报告
Clin Cosmet Investig Dermatol. 2025 Apr 3;18:797-800. doi: 10.2147/CCID.S494567. eCollection 2025.
2
Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis.托法替布成功治疗司库奇尤单抗诱发斑秃的掌跖脓疱病患者
Clin Cosmet Investig Dermatol. 2023 Oct 16;16:2879-2883. doi: 10.2147/CCID.S430156. eCollection 2023.
3
Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies.
掌跖脓疱病：风险因素与治疗的系统评价
Psoriasis (Auckl). 2023 Sep 22;13:33-58. doi: 10.2147/PTT.S400402. eCollection 2023.
4
mRNA Staining Distinguishes Palmoplantar Psoriasis from Hyperkeratotic Palmoplantar Eczema in Diagnostic Skin Biopsies.mRNA染色在诊断性皮肤活检中可区分掌跖银屑病与角化过度型掌跖湿疹。
JID Innov. 2023 Feb 10;3(4):100189. doi: 10.1016/j.xjidi.2023.100189. eCollection 2023 Jul.
5
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study.白细胞介素-17与白细胞介素-23抑制剂治疗脓疱型和红皮病型银屑病的回顾性多中心队列研究
J Clin Med. 2023 Feb 19;12(4):1662. doi: 10.3390/jcm12041662.